John R. Moore, General Counsel at Edgewise Therapeutics, Inc. (EWTX), sold 91,844 shares at $27.63 ($2.6M) on 2024-09-23, disclosed to the SEC on 2024-09-24.
Open-market sale of $2.6M EWTX by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.37 | 50,000 | $1.4M | 55.1% |
| 2 | $27.63 | 20,922 | $578K | 22.5% |
| 3 | $27.63 | 20,922 | $578K | 22.5% |
| Total | $28.03 avg | 91,844 | $2.6M | 100% |
| Filing → |
| EWTX | SELL | 2025-05-07 | $32K | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |
| EWTX | SELL | 2024-02-09 | $834K | — | Filing → |